ArticleDrug design, development and therapy2026
Risk of Bone Mineral Density Loss Associated with GLP-1 Receptor Agonists in Overweight COPD Populations [Response to Letter].
Sheng-Chi Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.